Skip to main content

3 Result(s)

within Philippe Bisel Remove this filter

and

  1. Article

    Open Access

    5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

    In recent years e-liquids used in electronic cigarettes have become an attractive alternative to smoking tobacco. A new trend is the use of e-liquids containing synthetic cannabinoids (SCs) instead of smoking ...

    Verena Angerer, Florian Franz, Bjoern Moosmann, Philippe Bisel… in Forensic Toxicology (2019)

    Download PDF (2358 KB) View Article

  2. No Access

    Article

    Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

    In 2012, the first designer benzodiazepines were offered in Internet shops as an alternative to prescription-only benzodiazepines. Soon after these compounds were scheduled in different countries, new substanc...

    Laura M. Huppertz, Philippe Bisel, Folker Westphal, Florian Franz… in Forensic Toxicology (2015)

  3. No Access

    Article

    Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures

    Recently, a large number of synthetic cannabinoids have been identified in herbal mixtures. Moreover, an even higher number of cannabimimetic compounds are currently distributed as research chemicals on a gram...

    Stefan Kneisel, Philippe Bisel, Volker Brecht, Sebastian Broecker… in Forensic Toxicology (2012)